Affiliation:
1. National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, 70013 Castellana Grotte, BA, Italy
Abstract
Inflammasomes are multiprotein complexes expressed by immune cells in response to distinct stimuli that trigger inflammatory responses and the release of pro-inflammatory cytokines. Evidence suggests a different role of inflammasome NLRP3 in IBD. NLRP3 inflammasome activation can be controlled by post-translational modifications such as ubiquitination through BRCC3. The aim of this study was to investigate the effect of miR-369-3p on the expression and activation of NLRP3 inflammasomes via BRCC3 regulation. After bioinformatics prediction of Brcc3 as a gene target of miR-369-3p, in vitro, we validated its modulation in bone marrow-derived macrophages (BMDM). The increase in miR-369-3p significantly reduced BRCC3 gene and protein expression. This modulation, in turn, reduced the expression of NLRP3 and blocked the recruitment of ASC adaptor protein by NLRP3. As a result, miR-369-3p reduced the activity of Caspase-1 by the inflammasome, decreasing the cleavage of pro-IL-1β and pro-IL-18. These results support a novel mechanism that seems to act on post-translational modification of NLRP3 inflammasome activation by BRCC3. This may be an interesting new target in the personalized treatment of inflammatory disorders, including IBD.
Funder
Italian Ministry of Health
Reference54 articles.
1. Inflammatory bowel disease: Pathogenesis;Zhang;World J. Gastroenterol.,2014
2. Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments;Garcia;Mediat. Inflamm.,2015
3. The Immunological Basis of Inflammatory Bowel Disease;Silva;Gastroenterol. Res. Pract.,2016
4. Immunological pathogenesis of inflammatory bowel disease;Lee;Intest. Res.,2018
5. NLRP3 Inflammasome and Inflammatory Bowel Disease;Zhen;Front. Immunol.,2019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献